Related Experiment Video
Updated: Jan 27, 2026

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
Mutational Testing in Gastrointestinal Stromal Tumor
1The Life Raft Group, 155 US-46 Wayne, NJ 07470, United States.
Abstract:
Targeted treatment has become a major modality in cancer management. Such cancer drugs are generally designed to treat tumors with certain genetic/genomic makeups. Mutational testing prior to prescribing targeted therapy is crucial in identifying who can receive clinical benefit from specific cancer drugs. Over the last two decades, gastrointestinal stromal tumors (GISTs) have evolved from histogenetically obscure to being identified as distinct gastrointestinal mesenchymal tumors with well-defined clinical and molecular characteristics, for which multiple lines of targeted therapies are available. Although the National Comprehensive Cancer Network (NCCN) strongly recommends mutational testing for optimal management of GIST, many GIST patients still have neither a mutation test performed or any mutation-guided cancer management. Here, we review the mutation-guided landscape of GIST, mutational testing methods, and the recent development of new therapies targeting GIST with specific mutations.
Insights
Mutational testing is essential for guiding targeted cancer therapy in gastrointestinal stromal tumors (GIST). Despite recommendations, many GIST patients do not receive mutation-guided management, highlighting a gap in care.
Area of Science:
- Oncology
- Genetics
- Gastroenterology
Background:
- Targeted cancer therapies are designed for tumors with specific genetic profiles.
- Gastrointestinal stromal tumors (GIST) are now recognized as distinct mesenchymal tumors with known molecular characteristics.
- Mutational testing is critical for effective targeted therapy selection in cancer management.
Purpose of the Study:
- To review the current landscape of mutation-guided therapy for GIST.
- To discuss various methods for mutational testing in GIST.
- To highlight recent advancements in targeted therapies for GIST based on specific mutations.
Main Methods:
- Literature review of GIST research.
- Analysis of clinical guidelines and recommendations (e.g., NCCN).
- Summary of current and emerging GIST mutational testing techniques.
Main Results:
- GIST has well-defined molecular characteristics, enabling targeted treatments.
- National Comprehensive Cancer Network (NCCN) guidelines recommend mutational testing for GIST.
- A significant number of GIST patients still lack mutation testing or mutation-guided management.
Conclusions:
- Mutation-guided therapy is crucial for optimizing GIST treatment outcomes.
- There is a need to improve the uptake of mutational testing in GIST patient care.
- Advances in targeted therapies offer new hope for GIST patients with specific mutations.
More Related Videos
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Anatomy of the Gastrointestinal System
Here's a detailed walkthrough of this complex system:
Mutation, Gene Flow, and Genetic Drift
Histology of the Gastrointestinal (GI) Tract
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...

